Skip to main content

Table 5 Multi-state model for the migraine preventive treatment: risk of discontinuation and analyzed covariates

From: Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study

 

From the 1st line

From the 2nd line

From the 3rd or higher

HR

SD

P

HR

SD

P

HR

SD

P

Agea

5.06

 < 0.001

 < 0.001

5.10

 < 0.001

 < 0.001

5.09

0.01

0.237

Gender

0.98

0.03

0.526

0.87

0.19

0.455

1.09

0.55

0.882

CCI

1.01

0.01

0.516

0.95

0.09

0.582

1.01

0.28

0.96

Time since diagnosis

0.99

0.01

0.048

0.97

0.04

0.432

1.04

0.11

0.730

Discontinuation (vs. 1st line)

n/a

0.24

0.35

 < 0.001

0.21

0.98

0.110

  1. CCI Charlson Comorbidity Index, HR hazard ratio, n/a not applicable, SD standard deviation, P p-value
  2. a5-year HR